Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 414
Gene Symbol: ARSD
ARSD
0.010 Biomarker phenotype BEFREE ASD children presented a reduced habituation in the P1 component and a decrease in the amplitude of the mismatch negativity indicating a lower auditory discrimination with respect to controls. 31728809 2020
Entrez Id: 54413
Gene Symbol: NLGN3
NLGN3
0.010 Biomarker phenotype BEFREE We clustered genes by similarity in phenomic profiles and used epistasis analysis to discover parallel networks centered on <i>CHD8•chd-7</i> and <i>NLGN3•nlg-1</i> that underlie mechanosensory hyperresponsivity and impaired habituation learning. 31754030 2020
Entrez Id: 80862
Gene Symbol: ZNRD1ASP
ZNRD1ASP
0.010 AlteredExpression phenotype BEFREE The ZNRD1-AS up-regulation was directly correlated with the N1 amplitude, while the RP11-819C21.1 increase after pain showed a correlation with the reduced N2/P2 amplitude and laser-pain habituation. 31782860 2020
Entrez Id: 26121
Gene Symbol: PRPF31
PRPF31
0.010 GeneticVariation phenotype BEFREE ZNRD1-AS and RP11-819C21.1 long non-coding RNA changes following painful laser stimulation correlate with laser-evoked potential amplitude and habituation in healthy subjects: A pilot study. 31782860 2020
Entrez Id: 51594
Gene Symbol: NBAS
NBAS
0.010 Biomarker phenotype BEFREE Our results show a significant negative correlation between prenatal CES-D scores and NBAS scores on "habituation" (p = 0.0001), "orientation" (p = 0.015), "motor system" (p < 0.0001), "autonomic stability" (p < 0.0001) dimensions, independently of other variables, including pre/postnatal anxiety and postnatal depressive symptoms. 31297657 2020
Entrez Id: 4353
Gene Symbol: MPO
MPO
0.010 AlteredExpression phenotype BEFREE Repeated NO training lead to habituation in so far as cerebral activity as well as MPO activity after 21 training sessions. 30709023 2019
Entrez Id: 8874
Gene Symbol: ARHGEF7
ARHGEF7
0.010 Biomarker phenotype BEFREE In two distinct auditory paradigms sensory gating, indexed as P50 suppression, and sensorimotor gating, indexed as prepulse inhibition (PPI), startle reactivity, and habituation of the eye-blink startle response were examined. 29769152 2019
Entrez Id: 51008
Gene Symbol: ASCC1
ASCC1
0.010 Biomarker phenotype BEFREE In two distinct auditory paradigms sensory gating, indexed as P50 suppression, and sensorimotor gating, indexed as prepulse inhibition (PPI), startle reactivity, and habituation of the eye-blink startle response were examined. 29769152 2019
Entrez Id: 695
Gene Symbol: BTK
BTK
0.010 Biomarker phenotype BEFREE <i>Drosophila</i> Bruton's Tyrosine Kinase Regulates Habituation Latency and Facilitation in Distinct Mushroom Body Neurons. 31530645 2019
Entrez Id: 958
Gene Symbol: CD40
CD40
0.010 Biomarker phenotype BEFREE In two distinct auditory paradigms sensory gating, indexed as P50 suppression, and sensorimotor gating, indexed as prepulse inhibition (PPI), startle reactivity, and habituation of the eye-blink startle response were examined. 29769152 2019
Entrez Id: 4036
Gene Symbol: LRP2
LRP2
0.010 GeneticVariation phenotype BEFREE We also propose possible pathophysiological explanations for the phenomenon and define a nomenclature of the associated features: early versus late DBS failure; tremor rebound versus habituation (to be preferred over tolerance). 31433906 2019
Entrez Id: 2641
Gene Symbol: GCG
GCG
0.010 Biomarker phenotype BEFREE Results identify hindbrain lactate deficiency as a stimulus for glucagon secretion, and imply that habituation of this critical counter-regulatory hormone to recurring hypoglycemia may involve one or more hypothalamic neurotransmitters characterized here by acclimation to this critical sensory stimulus. 31488323 2019
Entrez Id: 115482723
Gene Symbol: H3P40
H3P40
0.010 Biomarker phenotype BEFREE In two distinct auditory paradigms sensory gating, indexed as P50 suppression, and sensorimotor gating, indexed as prepulse inhibition (PPI), startle reactivity, and habituation of the eye-blink startle response were examined. 29769152 2019
Entrez Id: 8408
Gene Symbol: ULK1
ULK1
0.010 AlteredExpression phenotype BEFREE By restraining UNC-51 activity, RPM-1 inhibits autophagosome formation to affect axon termination, synapse maintenance and behavioral habituation. 31676756 2019
Entrez Id: 4790
Gene Symbol: NFKB1
NFKB1
0.010 Biomarker phenotype BEFREE In two distinct auditory paradigms sensory gating, indexed as P50 suppression, and sensorimotor gating, indexed as prepulse inhibition (PPI), startle reactivity, and habituation of the eye-blink startle response were examined. 29769152 2019
Entrez Id: 23263
Gene Symbol: MCF2L
MCF2L
0.010 GeneticVariation phenotype BEFREE We also propose possible pathophysiological explanations for the phenomenon and define a nomenclature of the associated features: early versus late DBS failure; tremor rebound versus habituation (to be preferred over tolerance). 31433906 2019
Entrez Id: 6505
Gene Symbol: SLC1A1
SLC1A1
0.010 AlteredExpression phenotype BEFREE Unilateral 6-hydroxydopamine (6-OHDA) lesions of the medial forebrain bundle in rats impaired working memory and long-term habituation, decreased dopamine (DA) levels in the medial prefrontal cortex (mPFC), dHPC and ventral hippocampus (vHPC), and decreased the mean density of 5-HT<sub>1A</sub> receptors and co-localization of 5-HT<sub>1A</sub> receptor and excitatory amino acid carrier 1-immunoreactive (EAAC1-ir) neurons in the dHPC compared to sham-operated rats. 31476331 2019
Entrez Id: 4791
Gene Symbol: NFKB2
NFKB2
0.010 Biomarker phenotype BEFREE Based on the PRVEP findings, it may be concluded that migraineurs have sensitization of P100 and impaired habituation of N75 especially during headache. 28974100 2018
Entrez Id: 6490
Gene Symbol: PMEL
PMEL
0.010 Biomarker phenotype BEFREE Based on the PRVEP findings, it may be concluded that migraineurs have sensitization of P100 and impaired habituation of N75 especially during headache. 28974100 2018
Entrez Id: 41
Gene Symbol: ASIC1
ASIC1
0.010 Biomarker phenotype BEFREE Olfactory behavior of wild-type (WT) and ASIC1-/- mice was evaluated by using three standard olfactory tests: (1) the buried food test, (2) the olfactory habituation test, and (3) the olfactory preference test. 28912013 2018
Entrez Id: 4940
Gene Symbol: OAS3
OAS3
0.010 Biomarker phenotype BEFREE Based on the PRVEP findings, it may be concluded that migraineurs have sensitization of P100 and impaired habituation of N75 especially during headache. 28974100 2018
Entrez Id: 1523
Gene Symbol: CUX1
CUX1
0.010 Biomarker phenotype BEFREE Based on the PRVEP findings, it may be concluded that migraineurs have sensitization of P100 and impaired habituation of N75 especially during headache. 28974100 2018
Entrez Id: 54112
Gene Symbol: GPR88
GPR88
0.010 Biomarker phenotype BEFREE In the free adaptation phase, Gpr88 <sup>-/-</sup> mice showed delayed habituation to the home cage, and increased frequency of same corner returns behavior in their alternation pattern. 29575471 2018
Entrez Id: 3176
Gene Symbol: HNMT
HNMT
0.010 AlteredExpression phenotype BEFREE Finally, lentiviral vectors were microinjected into the DVC to determine the effects of altered HNMT expression on MS. We found the following: 1) HNMT expression in the medulla oblongata of dogs and rats insusceptible to MS was higher than in susceptible animals; 2) tacrine dose-dependently promoted MS in both animals and raised histamine level in rat medulla oblongata; 3) blocking histaminergic neurotransmission in the DVC with promethazine inhibited MS; 4) rotatory stimulus induced an elevation in HNMT expression, and vestibular training elevated the basal level of HNMT in the DVC during habituation to MS; 5) in vivo transfection of a lentiviral vector packaged with the HNMT gene increased HNMT expression in the DVC and reduced MS; and 6) microinjection of a lentiviral vector driving the interference of HNMT gene expression in vivo significantly inhibited HNMT expression in the DVC and exacerbated MS. 29298819 2018
Entrez Id: 952
Gene Symbol: CD38
CD38
0.010 AlteredExpression phenotype BEFREE Exploratory sub-group analyses for severely ill patients and patients with high anxiety and strong habituation during exposure showed that DCS administration was associated with increased improvement during the 1-month follow-up period (t10 - t11) with medium to large effect sizes (range in effect size η<sup>2</sup><sub>p</sub> from .06 to .25). 30237105 2018